The goal of the ACSM Core Group is to ensure TB free communities through the mobilization of economic, community and political resources, by promoting ACSM activities for TB control at global and national levels, particularly through the mobilization of an additional US$31 billion for TB activity worldwide in the 2006-2015 period.

Aeras Global TB Vaccine Foundation was founded in 1997 to help develop new concepts and tools to control the global TB epidemic. Today the organization focuses solely on developing new vaccines against TB and ensuring their availability to all who need them. In February 2004, Aeras received a 5-year US$82.9 million grant for new TB vaccine development. It is the goal of Aeras to develop, test, characterize, license, manufacture and distribute at least one new TB vaccine within 10 years.

AFRO GLOBAL ALLIANCE, founded in 2003, consists of members with common objectives interested in reconciling the Afro Youths worldwide, educating and enforcement of human right, awareness campaign of epidemics and pandemics in our society. The inspiration to unfold this dream was led by Chief Austin Arinze Obiefuna, founder and President. AGA after series of meetings and deliberation the dream was finally unveiled. I call AGA! The basket of all NGO's.

As a leading international authority on public health, the Johns Hopkins Bloomberg School of Public Health is dedicated to protecting health and saving lives. Every day, the School works to keep millions around the world safe from illness and injury by pioneering new research, deploying its knowledge and expertise in the field and educating tomorrow's scientists and practitioners in the global defense of human life.

The Centers for Disease Control and Prevention (CDC) is one of the 13 major operating components of the Department of Health and Human Services (HHS), which is the principal agency in the United States government for protecting the health and safety of all Americans and for providing essential human services, especially for those people who are least able to help themselves. CDC is committed to achieving true improvements in people’s health. To do this, the agency is defining specific health impact goals to prioritize and focus its work and investments and measure progress.

For more than 50 years Edelman has built a reputation known for breakthrough strategy and programming that delivers valuable results to our clients. Our professionals across our global network strive to bring the highest level of personal and professional integrity to the execution of their job, every day. As a global organization it is all the more important that we be unified in all facets of how Edelman does business. Our expertise and role in the formation and dissemination of messages to all stakeholders is of value across the spectrum of traditional media as well as increasingly called upon by numerous new media options.

The International Federation of Red Cross and Red Crescent Societies is the world's largest humanitarian organization, providing assistance without discrimination as to nationality, race, religious beliefs, class or political opinions. The Federation's mission is to improve the lives of vulnerable people by mobilizing the power of humanity. Vulnerable people are those who are at greatest risk from situations that threaten their survival, or their capacity to live with an acceptable level of social and economic security and human dignity. Often, these are victims of natural disasters, poverty brought about by socio-economic crises, refugees, and victims of health emergencies.

KNCV Tuberculosefonds is een toonaangevende medische ontwikkelingsorganisatie die zich inzet voor het wereldwijd terugdringen van tuberculose. Met onze methode, ‘DOTS’ genezen wij overal ter wereld miljoenen mensen met tuberculose. Dat moet ook wel. Tuberculose is een wijdverbreide en ook weerbarstige ziekte: één derde van de wereldbevolking - twee miljard mensen - draagt de bacil bij zich. Slechts 1 op de 10 geïnfecteerde mensen krijgt actieve tuberculose en wordt ziek.

The purpose of the Working Group on New TB Drugs is to ensure that scientists, academics, pharmaceutical companies, donors, multilaterals, and patients themselves are working together to speed the development of new drugs for TB. The Working Group serves as a mechanism through which members individually and collectively support the field of TB drug research by providing input into core publications and public policy recommendations developed by the Partnership. It also aims to ensure close coordination between researchers working on new tools and public health stakeholders involved in TB control.

PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, we help provide appropriate health technologies and vital strategies that change the way people think and act.

RDRS Bangladesh (Rangpur Dinajpur Rural Service) is a respected, long-established development NGO working to empower the rural poor in northern Bangladesh for over 34 years. In 1997, RDRS became an autonomous organisation, governed by a Board of Trustees, as the Bangladesh field programme of the Geneva-based Lutheran World Federation/Department for World Service (LWF/DWS) was localised. RDRS retains close partnership links with LWF/DWS and its Related Agencies.

RESULTS is a nonprofit grassroots advocacy organization, committed to creating the political will to end hunger and the worst aspects of poverty. RESULTS is committed to individuals exercising their personal and political power by lobbying elected officials for effective solutions and key policies that affect hunger and poverty.

RESULTS UK is an international grassroots lobby group working to create the public and political will to end hunger and the worst aspects of poverty. RESULTS UK gives individuals the tools they need to take effective action and to speak out in favour of anti-poverty measures that really work.

Chaired by the Senior Minister for the Presidency, the launch of the National Partnership to Stop TB Uganda, Africa's 1st National TB Partnership, was a success including solid national press coverage and active stakeholder and partner participation. The ceremony included testimony by a former TB/HIV patient, by the business coalition which plans to make significant contributions regarding TB in the workplace, and by traditional healers and patient-activists who also will play a strong role within the partnership. Also in attendance at the meeting was the Permanent Secretary, the Director General of the Ministry of Health, the WHO country representative, the Internal Union Against Tuberculosis and Lung Disease deputy executive director, and Global Stop TB Partnership representative.

The Global Alliance for TB Drug Development is a public-private partnership driven to halt the rise and reverse the spread of the world’s oldest infectious disease by developing new, faster-acting and affordable tuberculosis medicines. The global health community is not equipped to confront today’s triple threat: exponential rapid spread of TB infection; rise of drug-resistant strains and dangerous interaction with the raging HIV epidemic. New, faster-acting TB medicines will yield dividends globally as shorter, simpler therapeutic and prophylactic regimens transform the fight against the disease.

The Global Fund to Fight AIDS, Tuberculosis and Malaria was created to dramatically increase resources to fight three of the world's most devastating diseases, and to direct those resources to areas of greatest need. As a partnership between governments, civil society, the private sector and affected communities, the Global Fund represents an innovative approach to international health financing. The Global Fund's purpose is to attract, manage and disburse resources to fight AIDS, TB and malaria. We do not implement programs directly, relying instead on the knowledge of local experts.

USAID's history goes back to the Marshall Plan reconstruction of Europe after World War Two and the Truman Administration's Point Four Program. In 1961, the Foreign Assistance Act was signed into law and USAID was created by executive order. Since that time, USAID has been the principal U.S. agency to extend assistance to countries recovering from disaster, trying to escape poverty, and engaging in democratic reforms.

The World Lung Foundation works in partnership with organizations throughout the world that share our mission of improving lung health. The Foundation cooperates closely with agencies working in the field of tuberculosis control, such as the STOP TB Partnership and the World Health Organization (WHO). In particular, the Foundation partners with the International Union Against Tuberculosis and Lung Disease (The Union), a nonprofit scientific organization that has played a leading role in the fight against tuberculosis and other lung diseases since 1920. Research by The Union led to the development of DOTS, the internationally recommended TB control strategy that has been adopted by the WHO for treatment and control of tuberculosis worldwide. Now, the Foundation partners with The Union to ensure wider and wiser application of DOTS, as well as to create new strategies to fight TB.

ACSM Working Group elections for Chair and Vice Chair

ACSM e-Update

Announcement: ACSM Working Group Meeting - 5 & 6 November 2007

European Regional Stop TB Partnership

G8 must commit itself to fighting TB

Tuberculosis and Air Travel

INTERNATIONAL HERALD TRIBUNE: Italian health authorities trace flights of American with rare form of tuberculosis

African Nations Should Allocate Enough Funds, Implement Policies To Meet MDGs, Including Goals To Combat AIDS, TB, Malaria, Advocates Say

"TB patients: Some don’t... some do, Some won’t... some will"

Action for Global Health has been started simultaneously in Brussels, France, Germany, Italy, Spain and the UK. They are monitoring how the actions and policies of European governments affect health in developing countries. They are inviting other NGOs and civil society organisations to join with them to build a European campaign to ensure that governments, the private sector and European institutions fulfil the promises they have made to reduce the rates of infant and maternal mortality and slowing down the spread of transmissible diseases in the world's poorest countries. To find out more click the link above.

Bulletin of the World Health Organization

Special theme: tuberculosis control; Promising new tools for prevention, detection and cure; How reliable are the data?; The Global Drugs Facility; Barriers to completing treatment; Russian region reports progress; Public health classic: lessons from the past; Interview: Jorge Sampaio, UN special envoy to Stop TB

Global map reveals XDR-TB cases

This month, WHO Stop TB launches a global map illustrating countries where XDR-TB has been confirmed, to coincide with preparations for countries to carry out rapid surveys of drug-resistance, as recommended by the WHO Global Task Force on XDR-TB in October 2006. The surveys will estimate the extent of XDR-TB within at-risk populations, and indicate whether further investigations are required. Laboratory capacity is being strengthened as part of the surveillance strategy, to ensure patients will have improved access to diagnosis and treatment of drug-resistant TB.

UNAIDS aligning with Stop TB
1 December, Geneva
Today Dr Peter Piot, Executive Director of UNAIDS, called for a collective response to MDR and XDR-TB
Read more here.

Dr Piots' speech to the Stop TB Partnership Coordinating Board

WHO Press Release, Jakarta, Indonesia
29 November 2006 - Killer diseases like tuberculosis (TB) and HIV/AIDS are often forgotten while the whole world’s attention is now focusing on new emerging and epidemic/ pandemic potential diseases.
Read More